Batiraxcept
Aravive’s Desperate Bid for Survival: Drastic Layoffs as Company Nears Liquidation
Anika Sharma
Aravive, a biotech company, is currently facing a critical juncture as it grapples with the aftermath of a disappointing Phase ...
PFS in Patients with Platinum-Resistant Ovarian Cancer Is Not Improved by Batiraxcept
SG Tylor
Source – Aravive The Phase III AXLerate-OC trial (NCT04300140) assessing the combination of batiraxcept with paclitaxel has not met its ...
